Marrone Bio Innovations (Marrone Bio Innovations) GF Value Rank : 8 (As of Jun. 15, 2024)

View and export this data going back to 2013. Start your Free Trial

What is Marrone Bio Innovations GF Value Rank?

Marrone Bio Innovations has the GF Value Rank of 8.

The GF Value Rank is determined by the price-to-GF-Value (P/GF Value) ratio, a proprietary metric calculated based on historical multiples along with an adjustment factor based on a company's past returns and growth and future estimates of the business' performance.

GuruFocus found that for valuation, we cannot simply give stocks a better GF Value rank simply because they have a lower P/GF Value ratio. Backtesting shows that over the long term, the two worst-performing groups are the most expensive group (with the highest P/GF Value ratio) and the least expensive group (with the lowest P/GF Value ratio).

We can understand why the most expensive group underperforms. We were initially puzzled by the underperformance of the least expensive group, but we realized there is a reason why some stocks are super cheap. If they look too undervalued, it is often because the businesses behind them are poor quality. The market realized this and gave them low valuations. In a way, the market is efficient.

After multiple backtesting analyses, we granted the stocks in third-cheapest percentile the highest GF Value rank, as they have performed the best over a full market cycle. Stock performance is actually not as sensitive to valuation as it is to growth and profitability. On average, the companies in the 20%-50% valuation groups have similar performances. Therefore, we should avoid the most expensive and the least expensive stocks. We can be more tolerant of valuation.

Please click GF Score to see more details on the GF Score's 5 Key Aspects of Analysis.

Competitive Comparison of Marrone Bio Innovations's GF Value Rank

For the Agricultural Inputs subindustry, Marrone Bio Innovations's GF Value Rank, along with its competitors' market caps and GF Value Rank data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Marrone Bio Innovations's GF Value Rank Distribution in the Agriculture Industry

For the Agriculture industry and Basic Materials sector, Marrone Bio Innovations's GF Value Rank distribution charts can be found below:

* The bar in red indicates where Marrone Bio Innovations's GF Value Rank falls into.

Marrone Bio Innovations GF Value Rank Related Terms

Thank you for viewing the detailed overview of Marrone Bio Innovations's GF Value Rank provided by GuruFocus.com. Please click on the following links to see related term pages.

Marrone Bio Innovations (Marrone Bio Innovations) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Agriculture » Marrone Bio Innovations Inc (NAS:MBII) » Definitions » GF Value Rank

Comparable Companies

Traded in Other Exchanges

N/A

Address

7780-420 Brier Creek Parkway,, Raleigh, NC, USA, 27617

Website

https://www.marronebioinnovations.com

Marrone Bio Innovations Inc is a US-based agricultural company engaged in the discovery, development and sale of innovative biological products for crop protection, crop health and crop nutrition. The company produces bio-based pest management and plant health products such as Biopesticides, Bioinsecticides, Bionematicides, Biofungicides, Biostimulants and Bionutrition, among others. It generates key revenue from the sales of Marrone products, mainly Regalia, Grandevo and Venerate.

Executives

Pamela G Marrone	director, officer: CEO and President	C/O MARRONE BIO INNOVATIONS, INC., 2121 SECOND STREET, A-107, DAVIS CA 95618
Ladon Johnson	officer: Interim CFO	C/O MARRONE BIO INNOVATIONS, INC. 7780-420 BRIER CREEK PARWAY RALEIGH NC 27617-7882
Ardsley Ridgecrest Partners Fund, L.p.	other: See Footnote (1)	262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Suping (sue) Cheung	officer: Chief Financial Officer	C/O QUICKLOGIC CORPORATION, SUNNYVALE CA 94089
Matti Tiainen	officer: SVP, International Sales	C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Lara L Lee	director	C/O MARRONE BIO INNOVATIONS, INC., 1540 DREW AVENUE, DAVIS CA 95618
Kevin Helash	director, officer: Chief Executive Officer	C/O MARRONE BIO INNOVATIONS, INC. 1540 DREW AVENUE DAVIS CA 95618
Ardsley Advisory Partners Gp Llc	other: See Footnotes(1)(2)	262 HARBOR DRIVE, 4TH FLOOR, STAMFORD CT 06902
Ospraie Management, Llc	director, 10 percent owner, other: (See Remarks)	437 MADISON AVENUE, 28TH FLOOR, NEW YORK NY 10022
Ospraie Management, Inc.	director, 10 percent owner, other: (See Remarks)	320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ospraie Holding I, L.p.	director, 10 percent owner, other: (See Remarks)	320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Dwight Anderson	director, 10 percent owner, other: (See Remarks)	C/O OSPRAIE MANAGEMENT, LLC, 320 PARK AVENUE, 27TH FLOOR, NEW YORK NY 10022
Ardsley Healthcare Fund, L.p.	other: See Footnote (1)	C/O ARDSLEY PARTNERS I GP, LLC, 262 HARBOR DRIVE, STAMFORD CT 06902
Ospraie Ag Science Llc	director, 10 percent owner, other: (See Remarks)	C/O DWIGHT ANDERSON 437 MADISON AVENUE, 28TH FLOOR NEW YORK NY 10022
Van Herk Investments B.v.	10 percent owner	LICHTENAUERLAAN 30 ROTTERDAM P7 3062ME